Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2021 Feb 2;27(3):256.e1–256.e7. doi: 10.1016/j.jtct.2020.12.021

Figure 2.

Figure 2.

Leukemia-Free Survival of all patients (A), Overall Survival of all patients (B), Overall Survival of CR1 patients (C), and Overall Survival of CR2 patients (D) by 2017 ELN genetic risk for AML